Baxter International (BAX) Net Profit Margin: History & Chart

Baxter International Inc.(BAX)

Medical - Instruments & Supplies · Deerfield, IL

$24.09-0.30 (-1.23%)

Delayed quote: Sep 10, 2026, 10:15 AM EDT

About Baxter International Inc.

Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.

Deerfield, IL

37,500 employees

www.baxter.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Andrew Hider

View full financials

BAX Net Profit Margin Metrics

NET PROFIT MARGIN

-9.27%

NET PROFIT MARGIN AVG TTM

-6.52%

NET PROFIT MARGIN AVG 3Y

0.76%

NET PROFIT MARGIN AVG 5Y

3.11%

NET PROFIT MARGIN AVG 10Y

6.58%

NET PROFIT MARGIN AVG 15Y

9.64%

NET PROFIT MARGIN AVG 20Y

11.06%

CURRENT VS TTM AVG

-42.13%

CURRENT VS 3Y AVG

-1313.75%

CURRENT VS 5Y AVG

-398.38%

CURRENT VS 10Y AVG

-240.79%

CURRENT VS 15Y AVG

-196.21%

CURRENT VS 20Y AVG

-183.80%

SECTOR MEDIAN · HEALTHCARE

9.21%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

-200.71%

vs the sector median at left

NAME	MARKET CAP	NET PROFIT MARGIN	TTM	3Y	5Y
Baxter International Inc. (BAX)	$12.45B	-9.27%	-6.52%	0.76%	3.11%
Penumbra, Inc. (PEN)vs ›	$12.57B	10.67%	6.92%	5.54%	3.35%
Encompass Health Corporation (EHC)vs ›	$12.11B	10.01%	9.01%	7.89%	8.30%
Charles River Laboratories International, Inc. (CRL)vs ›	$13.13B	-5.96%	-1.67%	5.09%	7.31%
DaVita Inc. (DVA)vs ›	$11.66B	6.05%	6.39%	5.83%	6.41%
Revvity, Inc. (RVTY)vs ›	$13.58B	8.16%	9.60%	8.02%	12.66%
Bio-Techne Corporation (TECH)vs ›	$11.32B	14.97%	10.50%	15.15%	16.71%
Align Technology, Inc. (ALGN)vs ›	$10.71B	9.99%	10.36%	10.48%	22.21%
The Cooper Companies, Inc. (COO)vs ›	$10.64B	13.46%	9.62%	9.77%	24.94%
Universal Health Services, Inc. (UHS)vs ›	$10.52B	8.42%	7.89%	6.46%	6.98%

NAME

MARKET CAP

NET PROFIT MARGIN

TTM

Baxter International Inc. (BAX)

$12.45B

-9.27%

-6.52%

0.76%

3.11%

Penumbra, Inc. (PEN)vs ›

$12.57B

10.67%

6.92%

5.54%

3.35%

Encompass Health Corporation (EHC)vs ›

$12.11B

10.01%

9.01%

7.89%

8.30%

Charles River Laboratories International, Inc. (CRL)vs ›

$13.13B

-5.96%

-1.67%

5.09%

7.31%

DaVita Inc. (DVA)vs ›

$11.66B

6.05%

6.39%

5.83%

6.41%

Revvity, Inc. (RVTY)vs ›

$13.58B

8.16%

9.60%

8.02%

12.66%

Bio-Techne Corporation (TECH)vs ›

$11.32B

14.97%

10.50%

15.15%

16.71%

Align Technology, Inc. (ALGN)vs ›

$10.71B

9.99%

10.36%

10.48%

22.21%

The Cooper Companies, Inc. (COO)vs ›

$10.64B

13.46%

9.62%

9.77%

24.94%

Universal Health Services, Inc. (UHS)vs ›

$10.52B

8.42%

7.89%

6.46%

6.98%

Net Profit Margin FAQ

What is the net profit margin for Baxter International Inc. (BAX)?

The net profit margin for BAX stock is -9.27%.

Is Baxter International Inc.'s net profit margin high or low?

The net profit margin of -9.27% is 398% below its 5-year average of 3.11%, around the middle of its 5-year range (-81.38%–96.50%).

What is the TTM average net profit margin for Baxter International Inc. (BAX)?

The TTM average net profit margin for BAX stock is -6.52%.

What is the 3Y average net profit margin for Baxter International Inc. (BAX)?

The 3Y average net profit margin for BAX stock is 0.76%.

What is the 5Y average net profit margin for Baxter International Inc. (BAX)?

The 5Y average net profit margin for BAX stock is 3.11%.

What is the 10Y average net profit margin for Baxter International Inc. (BAX)?

The 10Y average net profit margin for BAX stock is 6.58%.

What is the 15Y average net profit margin for Baxter International Inc. (BAX)?

The 15Y average net profit margin for BAX stock is 9.64%.

What is the 20Y average net profit margin for Baxter International Inc. (BAX)?

The 20Y average net profit margin for BAX stock is 11.06%.

DATE	NET PROFIT MARGIN
2026-06-30	4.26%
2026-03-31	-0.56%
2025-12-31	-37.93%
2025-09-30	-1.62%
2025-06-30	3.24%
2025-03-31	4.80%
2024-12-31	-18.60%
2024-09-30	5.19%
2024-06-30	-11.66%
2024-03-31	1.49%
2023-12-31	6.31%
2023-09-30	96.50%
2023-06-30	-3.80%
2023-03-31	1.25%
2022-12-31	4.66%
2022-09-30	-81.38%
2022-06-30	7.01%
2022-03-31	1.92%
2021-12-31	6.77%
2021-09-30	13.95%
2021-06-30	9.62%
2021-03-31	10.12%
2020-12-31	5.28%
2020-09-30	11.98%
2020-06-30	9.05%
2020-03-31	11.85%
2019-12-31	-0.76%
2019-09-30	12.94%
2019-06-30	11.04%
2019-03-31	12.96%
2018-12-31	12.25%
2018-09-30	18.76%
2018-06-30	12.07%
2018-03-31	14.53%
2017-12-31	-2.56%
2017-09-30	9.27%
2017-06-30	10.17%
2017-03-31	10.99%
2016-12-31	9.19%
2016-09-30	5.08%
2016-06-30	46.89%
2016-03-31	142.32%
2015-12-31	7.88%
2015-09-30	0.04%
2015-06-30	13.41%
2015-03-31	17.89%
2014-12-31	21.31%
2014-09-30	17.28%
2014-06-30	12.52%
2014-03-31	14.45%
2013-12-31	7.46%
2013-09-30	14.66%
2013-06-30	16.08%
2013-03-31	16.01%
2012-12-31	13.16%
2012-09-30	16.77%
2012-06-30	18.51%
2012-03-31	17.36%
2011-12-31	12.88%
2011-09-30	16.56%
2011-06-30	17.39%
2011-03-31	17.36%
2010-12-31	12.09%
2010-09-30	16.28%
2010-06-30	16.75%
2010-03-31	-2.15%
2009-12-31	16.48%
2009-09-30	16.85%
2009-06-30	18.80%
2009-03-31	18.27%
2008-12-31	18.17%
2008-09-30	14.98%
2008-06-30	17.06%
2008-03-31	14.91%
2007-12-31	15.89%
2007-09-30	14.36%
2007-06-30	15.24%
2007-03-31	15.07%
2006-12-31	15.60%
2006-09-30	14.63%
2006-06-30	11.66%
2006-03-31	11.71%
2005-12-31	11.72%
2005-09-30	4.84%
2005-06-30	12.50%
2005-03-31	9.48%
2004-12-31	4.08%
2004-09-30	11.90%
2004-06-30	-7.15%
2004-03-31	8.06%
2003-12-31	14.62%
2003-09-30	11.54%
2003-06-30	1.62%
2003-03-31	10.82%
2002-12-31	0.44%
2002-09-30	15.03%

DATE

NET PROFIT MARGIN

2026-06-30

4.26%

2026-03-31

-0.56%

2025-12-31

-37.93%

2025-09-30

-1.62%

2025-06-30

3.24%

2025-03-31

4.80%

2024-12-31

-18.60%

2024-09-30

5.19%

2024-06-30

-11.66%

2024-03-31

1.49%

2023-12-31

6.31%

2023-09-30

96.50%

2023-06-30

-3.80%

2023-03-31

1.25%

2022-12-31

4.66%

2022-09-30

-81.38%

2022-06-30

7.01%

2022-03-31

1.92%

2021-12-31

6.77%

2021-09-30

13.95%

2021-06-30

9.62%

2021-03-31

10.12%

2020-12-31

5.28%

2020-09-30

11.98%

2020-06-30

9.05%

2020-03-31

11.85%

2019-12-31

-0.76%

2019-09-30

12.94%

2019-06-30

11.04%

2019-03-31

12.96%

2018-12-31

12.25%

2018-09-30

18.76%

2018-06-30

12.07%

2018-03-31

14.53%

2017-12-31

-2.56%

2017-09-30

9.27%

2017-06-30

10.17%

2017-03-31

10.99%

2016-12-31

9.19%

2016-09-30

5.08%

2016-06-30

46.89%

2016-03-31

142.32%

2015-12-31

7.88%

2015-09-30

0.04%

2015-06-30

13.41%

2015-03-31

17.89%

2014-12-31

21.31%

2014-09-30

17.28%

2014-06-30

12.52%

2014-03-31

14.45%

2013-12-31

7.46%

2013-09-30

14.66%

2013-06-30

16.08%

2013-03-31

16.01%

2012-12-31

13.16%

2012-09-30

16.77%

2012-06-30

18.51%

2012-03-31

17.36%

2011-12-31

12.88%

2011-09-30

16.56%

2011-06-30

17.39%

2011-03-31

17.36%

2010-12-31

12.09%

2010-09-30

16.28%

2010-06-30

16.75%

2010-03-31

-2.15%

2009-12-31

16.48%

2009-09-30

16.85%

2009-06-30

18.80%

2009-03-31

18.27%

2008-12-31

18.17%

2008-09-30

14.98%

2008-06-30

17.06%

2008-03-31

14.91%

2007-12-31

15.89%

2007-09-30

14.36%

2007-06-30

15.24%

2007-03-31

15.07%

2006-12-31

15.60%

2006-09-30

14.63%

2006-06-30

11.66%

2006-03-31

11.71%

2005-12-31

11.72%

2005-09-30

4.84%

2005-06-30

12.50%

2005-03-31

9.48%

2004-12-31

4.08%

2004-09-30

11.90%

2004-06-30

-7.15%

2004-03-31

8.06%

2003-12-31

14.62%

2003-09-30

11.54%

2003-06-30

1.62%

2003-03-31

10.82%

2002-12-31

0.44%

2002-09-30

15.03%

Net Profit Margin: -9.27%

BAX Profit Margin

BAX Average Net Profit Margin Chart

BAX Current vs Average Net Profit Margin Chart

BAX Net Profit Margin Metrics

BAX Competitors' Net Profit Margin

Margin Comparison

Net Profit Margin Formula & Definition

Net Profit Margin FAQ

BAX Net Profit Margin History

Related Metrics